# MBX (MBX Biosciences, Inc.) - SEC EDGAR Financial Statements

> MBX Biosciences, Inc. reported $500.6M in total assets and a net loss of $145.1M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/MBX
- Markdown: https://convexityos.com/fundamentals/MBX.md
- SEC CIK: 0001776111
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:21 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001776111&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$160.3M | Operating profit |
| Net Income | FY 2025 | -$145.1M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.99 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$99.33M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $481.6M | Total debt: $3.29M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Research & Development | $79.16M | $57.41M | $28.53M |
| Total Operating Expenses | $98.06M | $68.19M | $35.31M |
| **Operating Income** | -$98.06M | -$68.19M | -$35.31M |
| **EBITDA** | -$97.81M | -$67.95M | -$35.15M |
| Income Before Tax | -$87.00M | -$61.90M | -- |
| Income Tax Expense | $0 | $0 | $0 |
| **Net Income** | -$87.00M | -$61.92M | -$32.56M |
| Basic EPS | -$2.38 | -$5.82 | -$31.96 |
| **Diluted EPS** | -$2.38 | -$5.82 | -$31.96 |
| Basic Shares Outstanding | 36.5M | 10.6M | 1.0M |
| Diluted Shares Outstanding | 36.5M | 10.6M | 1.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $32.05M | $30.98M | $18.47M | $19.76M | $19.27M | $17.72M | $22.41M | $15.22M |
| Total Operating Expenses | $66.34M | $40.93M | $27.27M | $25.80M | $23.93M | $21.80M | $26.53M | $18.61M |
| **Operating Income** | -$66.34M | -$40.93M | -$27.27M | -$25.80M | -$23.93M | -$21.80M | -$26.53M | -$18.61M |
| **EBITDA** | -$66.24M | -$40.83M | -$27.20M | -$25.73M | -$23.83M | -$21.70M | -$26.45M | -$18.55M |
| **Net Income** | -$62.42M | -$37.09M | -$23.52M | -$22.09M | -$21.62M | -$19.41M | -$23.88M | -$15.59M |
| Basic EPS | -$1.29 | -$0.78 | -$0.50 | -- | -$0.63 | -$0.58 | -$0.71 | -- |
| **Diluted EPS** | -$1.29 | -$0.78 | -$0.50 | -- | -$0.63 | -$0.58 | -$0.71 | -- |
| Basic Shares Outstanding | 48.6M | 47.7M | 46.6M | -- | 34.2M | 33.4M | 33.4M | -- |
| Diluted Shares Outstanding | 48.6M | 47.7M | 46.6M | -- | 34.2M | 33.4M | 33.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $75.29M | $49.35M | $30.52M |
| Short-Term Investments | $298.4M | $212.8M | $50.15M |
| **Cash & Short-Term Investments** | $373.7M | $262.1M | $80.68M |
| Other Current Assets | $861K | $803K | $133K |
| **Total Current Assets** | $381.5M | $267.3M | $83.47M |
| Property, Plant & Equipment, Net | $2.73M | $1.08M | $439K |
| Other Non-Current Assets | $383K | $50K | $50K |
| **Total Non-Current Assets** | $3.60M | $1.25M | $715K |
| **Total Assets** | $385.1M | $268.5M | $84.18M |
| Accounts Payable | $2.98M | $5.33M | $1.39M |
| **Total Current Liabilities** | $15.49M | $11.05M | $3.93M |
| **Total Non-Current Liabilities** | $426K | $42K | $365K |
| **Total Liabilities** | $15.92M | $11.09M | $4.29M |
| **Total Debt (incl. Leases)** | $596K | $171K | $324K |
| Common Stock | $6.0K | $5.0K | $1.0K |
| Retained Earnings | -$224.5M | -$137.5M | -$75.58M |
| Accumulated Other Comp. Income | $286K | $55K | $60K |
| **Total Stockholders' Equity** | $369.2M | $257.4M | -$72.47M |
| Total Equity | $369.2M | $257.4M | -$72.47M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $161.7M | $54.12M | $45.21M | $75.29M | $223.1M | $39.78M | $29.90M | $49.35M |
| Short-Term Investments | $319.9M | $364.5M | $394.8M | $298.4M | $168.5M | $185.1M | $210.9M | $212.8M |
| **Cash & Short-Term Investments** | $481.6M | $418.6M | $440.0M | $373.7M | $391.7M | $224.9M | $240.8M | $262.1M |
| Other Current Assets | $2.48M | $1.16M | $814K | $861K | $882K | $472K | $626K | $803K |
| **Total Current Assets** | $492.8M | $427.9M | $448.5M | $381.5M | $397.5M | $229.2M | $244.3M | $267.3M |
| Property, Plant & Equipment, Net | $5.00M | $4.66M | $3.13M | $2.73M | $2.00M | $1.73M | $1.51M | $1.08M |
| Other Non-Current Assets | $247K | $625K | $579K | $383K | $50K | $50K | $50K | $50K |
| **Total Non-Current Assets** | $7.86M | $8.05M | $4.17M | $3.60M | $2.57M | $2.33M | $1.65M | $1.25M |
| **Total Assets** | $500.6M | $435.9M | $452.7M | $385.1M | $400.1M | $231.5M | $245.9M | $268.5M |
| Accounts Payable | $6.80M | $4.36M | $6.97M | $2.98M | $3.77M | $5.76M | $4.25M | $5.33M |
| **Total Current Liabilities** | $25.17M | $23.66M | $14.57M | $15.49M | $12.06M | $11.76M | $10.48M | $11.05M |
| **Total Non-Current Liabilities** | $2.50M | $2.71M | $378K | $426K | $476K | $527K | $23K | $42K |
| **Total Liabilities** | $27.67M | $26.37M | $14.95M | $15.92M | $12.54M | $12.28M | $10.50M | $11.09M |
| **Total Debt (incl. Leases)** | $3.29M | $3.34M | $555K | $596K | $623K | $650K | $130K | $171K |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K |
| Retained Earnings | -$347.5M | -$285.1M | -$248.0M | -$224.5M | -$202.4M | -$180.8M | -$161.4M | -$137.5M |
| Accumulated Other Comp. Income | -$1.96M | -$1.22M | -$606K | $286K | $154K | $11K | $53K | $55K |
| **Total Stockholders' Equity** | $472.9M | $409.5M | $437.8M | $369.2M | $387.5M | $219.2M | $235.4M | $257.4M |
| Total Equity | $472.9M | $409.5M | $437.8M | $369.2M | $387.5M | $219.2M | $235.4M | $257.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$86.97M | -$61.92M | -$32.56M |
| Depreciation & Amortization | $248K | $244K | $157K |
| Stock-Based Compensation | $8.68M | $5.22M | $2.04M |
| Change in Payables | -$2.46M | $3.93M | $412K |
| **Operating Cash Flow** | -$79.95M | -$54.68M | -$31.98M |
| Capital Expenditure | -$1.93M | -$874K | -$129K |
| **Free Cash Flow** | -$81.88M | -$55.55M | -$32.11M |
| Purchases of Investments | -$358.1M | -$239.5M | -$63.80M |
| **Investing Cash Flow** | -$83.70M | -$160.6M | -$30.93M |
| Common Stock Issued | $601.7M | -- | -- |
| **Financing Cash Flow** | $189.6M | $234.1M | $69.22M |
| **Net Change in Cash** | $25.94M | $18.83M | $6.31M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$62.42M | -$37.09M | -$23.52M | -$22.06M | -$21.62M | -$19.41M | -$23.88M | -$15.59M |
| Depreciation & Amortization | $100K | $100K | $64K | $60K | $100K | $100K | $77K | $58K |
| Stock-Based Compensation | $27.55M | $6.06M | $5.48M | $2.66M | $2.25M | $1.94M | $1.84M | $1.49M |
| Change in Payables | $3.17M | -$3.23M | $3.97M | -$861K | -$2.04M | $2.01M | -$1.56M | $645K |
| **Operating Cash Flow** | -$34.88M | -$22.62M | -$20.21M | -$18.30M | -$21.54M | -$17.43M | -$22.68M | -$16.04M |
| Capital Expenditure | -$1.19M | -$901K | -$437K | -$793K | -$399K | -$707K | -$30K | -$92K |
| **Free Cash Flow** | -$36.07M | -$23.52M | -$20.64M | -$19.09M | -$21.93M | -$18.14M | -$22.71M | -$16.13M |
| Purchases of Investments | -$29.73M | -$53.89M | -$154.2M | -$205.4M | -$46.40M | -$47.43M | -$58.89M | -$87.50M |
| **Investing Cash Flow** | $42.83M | $29.21M | -$97.10M | -$130.0M | $17.06M | $25.99M | $3.23M | -$67.34M |
| Common Stock Issued | -- | $0 | $688.8M | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $99.61M | $2.32M | $87.44M | $438K | $187.8M | $1.33M | $4.0K | -$132K |
| **Net Change in Cash** | $107.6M | $8.91M | -$29.87M | -$147.8M | $183.3M | $9.88M | -$19.45M | -$83.51M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Return on Equity (ROE) | -23.6% | -24.1% | -- |
| Return on Assets (ROA) | -22.6% | -23.1% | -38.7% |
| Current Ratio | 24.62x | 24.19x | 21.26x |
| Quick Ratio | 24.12x | 23.72x | 20.55x |
| Debt to Equity | 0.00x | 0.00x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -30.7% | -25.5% | -19.8% | -23.6% | -20.8% | -35.1% | -31.2% | -24.1% |
| Return on Assets (ROA) | -29.0% | -23.9% | -19.1% | -22.6% | -20.1% | -33.3% | -29.9% | -23.1% |
| Current Ratio | 19.58x | 18.08x | 30.79x | 24.62x | 32.95x | 19.50x | 23.31x | 24.19x |
| Quick Ratio | 19.14x | 17.69x | 30.21x | 24.12x | 32.47x | 19.13x | 22.97x | 23.72x |
| Debt to Equity | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
